Search

For the first time, researchers have found an association between the makeup of the microorganisms in the body before a bone marrow transplant and a patient’s survival afterward.

… Sunday, December 2, 2018 Summary For the first time, researchers have found that having a healthy balance of microorganisms in the body before a bone marrow transplant is associated with higher survival rates after the transplant. Update: On February 27, 2020, Dr. Peled, Dr. van den Brink, and their

New MSK research suggests a method for revealing DNA repair “scars” could help make treatment decisions in BRCA1- and BRCA2-deficient cancers; modified a bacteria-made compound to target mutant KRAS-driven cancers; and shed new light on brain metastasis in non-small cell lung cancer.

… Thursday, August 24, 2023 New research from  Memorial Sloan Kettering Cancer Center (MSK)  and the  Sloan Kettering Institute  — a hub for basic science and translational research within MSK — suggests a method for revealing DNA repair “scars” could help make treatment decisions in BRCA1- and BRCA2-deficient

… Tea will be served at 10:15 a.m. , immediately preceding the seminar. Audience This seminar is open to the research community. Location Memorial Sloan Kettering Cancer Center 1275 York Avenue Room M-107 New York, NY 10065 Speaker(s) Connor Coley, PhD Associate Professor Department of Chemical Engineering

A new drug is being shown to extend the lives of patients with advanced soft tissue sarcoma by almost a year. The results of a multicenter phase II trial evaluating the efficacy and safety of olaratumab in combination with doxorubicin chemotherapy was published in The Lancet on June 9. William Tap, MD, Chief of the Sarcoma Medical Oncology Service at Memorial Sloan Kettering Cancer Center (MSK), served as corresponding author on this study, which met its primary endpoint of progression-free survival and showed a statistically significant improvement in overall survival. To arrange an interview with Dr. Tap, please email [email protected].

… Friday, June 10, 2016 A new drug is being shown to extend the lives of patients with advanced soft tissue sarcoma by almost a year. The results of a multicenter phase II trial evaluating the efficacy and safety of olaratumab in combination with doxorubicin chemotherapy was published in The Lancet on

Dr. William Christopher Newman treats spinal and metastatic tumors at MSK using minimally invasive surgery and advanced pain management to preserve patients' quality of life.

… Dr. William Christopher Newman treats spinal and metastatic tumors at MSK using minimally invasive surgery and advanced pain management to preserve patients’ quality of life. Cancer of the spine can be life-altering not just for the person diagnosed, but for their entire family. That’s why treating spinal

… Job Title Research Associate

… Effective Date: June 18, 2021 This Privacy Policy (this “Policy”) is designed to inform you about how we collect, use and share information about you when you access or use the TEAMWork mobile application associated with the research study named Talking to Employers and Medical Staff About Work (TEAMWork

June 18, 2021

… Effective Date: June 18, 2021 El objetivo de la presente Política de privacidad (esta “Política”) es informar sobre la manera en que recabamos, utilizamos y compartimos la información personal cuando usted accede o utiliza la aplicación móvil TEAMWork del estudio de investigación denominado “Hablar con

Memorial Sloan Kettering medical oncologist Robert Motzer specializes in treating kidney cancer (renal cell carcinoma).

… Genitourinary Medical Oncologist Job Title Section Head, Kidney Cancer, Genitourinary Oncology Service; Jack and Dorothy Byrne Chair in Clinical Oncology I am a medical oncologist who is dedicated to improving the lives of people with genitourinary cancer. My primary area of expertise is kidney cancer

Robert Motzer, médico oncólogo del Memorial Sloan Kettering, se especializa en el tratamiento del cáncer de riñón (carcinoma de las células renales).

… Genitourinary Oncologist Job Title Jefe de Sección, Cáncer de Riñón, Servicio de Oncología Genitourinaria; Cátedra Jack y Dorothy Byrne de Oncología Clínica Soy médico oncólogo y me dedico a mejorar la vida de las personas con cáncer genitourinario. Mi principal área de experiencia es el cáncer de riñón